The First Affiliated Hospital of Chongqing Medical University — Chongqing, Chongqing Municipality

Public research footprint of The First Affiliated Hospital of Chongqing Medical University, compiled from the ClinicalTrials.gov public registry.

421

Registered studies

225

Active

124

Recruiting now

106

Completed

Stopped or withdrawn

Most-studied conditions

Chronic Lymphocytic Leukemia · Mantle Cell Lymphoma · Metastatic Castration Sensitive Prostate Cancer (mCSPC) · Small Lymphocytic Lymphoma

Recently updated registry entries

NCT06841354 — A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination… (Recruiting)
NCT07741045 — Phase Ⅲ Clinical Trial to Evaluate the Efficacy and Safety of TJ0113 Capsules in Patients… (Not Yet Recruiting)
NCT07230119 — A Study of Zovaglutide in Subjects With Overweight or Obesity (HORIZON-1) (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at The First Affiliated Hospital of Chongqing Medical University?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.